US health panel recommends easing access to controversial peptides

A panel of federal health advisers has narrowly recommended easing restrictions on several peptides popular among wellness influencers and celebrities, despite warnings from government scientists. The chemicals, including BPC-157, TB-500, and KPV, have not been proven safe or effective for medical use.

In a series of votes, the outside experts advising the Food and Drug Administration (FDA) voted 8-6, with one abstention, to remove current restrictions that prevent pharmacies from producing injectable peptides. If the FDA accepts this advice, telehealth companies are expected to increase marketing of these chemicals for wellness and cosmetic purposes.

The panel's makeup raised concerns, as several members with connections to the peptide industry were added shortly before the meeting. These included doctors, pharmacists, and consultants working in the field. "I voted yes because it’s time to put this decision back in the hands of the patient, the physician and the pharmacist," stated David Pope, chief pharmacy officer of Xifin Pharmacy Solutions, after the vote on BPC-157.

“

I voted yes because it’s time to put this decision back in the hands of the patient, the physician and the pharmacist.

Panel members with academic backgrounds, rather than direct ties to the peptide industry, largely voted against the substances. "I’m concerned we’re responding to a market-induced demand rather than a decision based in solid science," said Dr. Elizabeth Rebello of the University of Texas MD Anderson Center. FDA staff scientists presented highly critical reviews, citing a lack of data supporting the safe medical use of these peptides.

Peptide supporters include podcaster Joe Rogan and longevity influencers. However, medical experts describe the current market as a "wild west" of unproven drugs that could pose serious health risks, including infection and allergic reactions. Peptides are the building blocks of proteins, and while some have been approved as medications for conditions like diabetes and weight loss, most sold online are promoted for unproven uses.

“

I’m concerned we’re responding to a market-induced demand rather than a decision based in solid science.